Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rachel Roberts

Showing results (151-160 of 186) with videos related to

Pageof 19
Sort By:
Frontiers in Oncology|December 25, 2025
A phase Ib/II study of modakafusp alfa alone and in combination with pembrolizumab in patients with advanced or metastatic solid tumorsDavid Gill, Charles L Cowey, Gregory A Daniels, et al.
Frontiers in Immunology|July 22, 2025
R21/Matrix-M malaria vaccine drives diverse immune responses in pre-exposed adults: insights from a phase IIb controlled human malaria infection trialElizabeth Kibwana, Caroline Bundi, Domtila Kimani, et al.
Lung Cancer (Amsterdam, Netherlands)|September 20, 2024
Patient-reported outcomes in CodeBreaK 200: Sotorasib versus docetaxel for previously treated advanced NSCLC with KRAS G12C mutationDavid M Waterhouse, Sacha Rothschild, Christophe Dooms, et al.
Scientific Reports|February 23, 2018
Assessment of novel vaccination regimens using viral vectored liver stage malaria vaccines encoding ME-TRAPCarly M Bliss, Georgina Bowyer, Nicholas A Anagnostou, et al.
Nature Communications|July 31, 2021
A single dose of ChAdOx1 Chik vaccine induces neutralizing antibodies against four chikungunya virus lineages in a phase 1 clinical trialPedro M Folegatti, Kate Harrison, Lorena Preciado-Llanes, et al.
Science Translational Medicine|September 28, 2018
Prime and target immunization protects against liver-stage malaria in miceAnita Gola, Daniel Silman, Adam A Walters, et al.
Plos One|December 13, 2018
First field efficacy trial of the ChAd63 MVA ME-TRAP vectored malaria vaccine candidate in 5-17 months old infants and childrenAlfred B Tiono, Issa Nébié, Nicholas Anagnostou, et al.
Plos One|December 16, 2016
Safety, Immunogenicity and Efficacy of Prime-Boost Vaccination with ChAd63 and MVA Encoding ME-TRAP against Plasmodium falciparum Infection in Adults in SenegalVictorine A Mensah, Aly Gueye, Magatte Ndiaye, et al.
Frontiers in Immunology|December 8, 2017
Safety and Immunogenicity of Malaria Vectored Vaccines Given with Routine Expanded Program on Immunization Vaccines in Gambian Infants and Neonates: A Randomized Controlled TrialVictorine A Mensah, Sophie Roetynck, Ebrima K Kanteh, et al.
Wellcome Open Research|April 13, 2026
Phase I/IIa study to assess the safety, immunogenicity and efficacy of ChAdOx1-MVA vectored vaccines expressing a novel liver-stage malaria dual antigen LS2 by sporozoite challenge in malaria-naïve adultsDaniel Silman, Amy Flaxman, Mehreen Datoo, et al.
Pageof 19

Showing results (151-160 of 186) with videos related to

Sort By:
Pageof 19
Frontiers in Oncology|December 25, 2025
A phase Ib/II study of modakafusp alfa alone and in combination with pembrolizumab in patients with advanced or metastatic solid tumorsDavid Gill, Charles L Cowey, Gregory A Daniels, et al.
Frontiers in Immunology|July 22, 2025
R21/Matrix-M malaria vaccine drives diverse immune responses in pre-exposed adults: insights from a phase IIb controlled human malaria infection trialElizabeth Kibwana, Caroline Bundi, Domtila Kimani, et al.
Lung Cancer (Amsterdam, Netherlands)|September 20, 2024
Patient-reported outcomes in CodeBreaK 200: Sotorasib versus docetaxel for previously treated advanced NSCLC with KRAS G12C mutationDavid M Waterhouse, Sacha Rothschild, Christophe Dooms, et al.
Scientific Reports|February 23, 2018
Assessment of novel vaccination regimens using viral vectored liver stage malaria vaccines encoding ME-TRAPCarly M Bliss, Georgina Bowyer, Nicholas A Anagnostou, et al.
Nature Communications|July 31, 2021
A single dose of ChAdOx1 Chik vaccine induces neutralizing antibodies against four chikungunya virus lineages in a phase 1 clinical trialPedro M Folegatti, Kate Harrison, Lorena Preciado-Llanes, et al.
Science Translational Medicine|September 28, 2018
Prime and target immunization protects against liver-stage malaria in miceAnita Gola, Daniel Silman, Adam A Walters, et al.
Plos One|December 13, 2018
First field efficacy trial of the ChAd63 MVA ME-TRAP vectored malaria vaccine candidate in 5-17 months old infants and childrenAlfred B Tiono, Issa Nébié, Nicholas Anagnostou, et al.
Plos One|December 16, 2016
Safety, Immunogenicity and Efficacy of Prime-Boost Vaccination with ChAd63 and MVA Encoding ME-TRAP against Plasmodium falciparum Infection in Adults in SenegalVictorine A Mensah, Aly Gueye, Magatte Ndiaye, et al.
Frontiers in Immunology|December 8, 2017
Safety and Immunogenicity of Malaria Vectored Vaccines Given with Routine Expanded Program on Immunization Vaccines in Gambian Infants and Neonates: A Randomized Controlled TrialVictorine A Mensah, Sophie Roetynck, Ebrima K Kanteh, et al.
Wellcome Open Research|April 13, 2026
Phase I/IIa study to assess the safety, immunogenicity and efficacy of ChAdOx1-MVA vectored vaccines expressing a novel liver-stage malaria dual antigen LS2 by sporozoite challenge in malaria-naïve adultsDaniel Silman, Amy Flaxman, Mehreen Datoo, et al.
Pageof 19